Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.22 - $0.58 $44 - $115
200 New
200 $0
Q1 2023

May 17, 2023

BUY
$1.1 - $2.86 $110 - $286
100 Added 100.0%
200 $0
Q4 2022

Feb 13, 2023

BUY
$0.92 - $96.0 $92 - $9,600
100 New
100 $0

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.